|
|
Volumn 29, Issue 5, 2004, Pages 11-15
|
|
Treatment and prevention of dyslipidemia with rosuvastatin (Crestor).
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ROSUVASTATIN;
SULFONAMIDE;
BIOAVAILABILITY;
CLINICAL TRIAL;
DRUG MONITORING;
HALF LIFE TIME;
HUMAN;
HYPERLIPIDEMIA;
INTESTINE ABSORPTION;
METABOLIC CLEARANCE RATE;
NURSE PRACTITIONER;
NURSING;
ORAL DRUG ADMINISTRATION;
PATIENT EDUCATION;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PRIMARY HEALTH CARE;
REVIEW;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
BIOLOGICAL AVAILABILITY;
CLINICAL TRIALS;
DRUG MONITORING;
FLUOROBENZENES;
HALF-LIFE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
INTESTINAL ABSORPTION;
METABOLIC CLEARANCE RATE;
NURSE PRACTITIONERS;
PATIENT EDUCATION;
PATIENT SELECTION;
PRACTICE GUIDELINES;
PRIMARY HEALTH CARE;
PYRIMIDINES;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 2942652854
PISSN: 03611817
EISSN: None
Source Type: Journal
DOI: 10.1097/00006205-200405000-00003 Document Type: Review |
|
Times cited : (1)
|
|
References (26)
|
